Abstract:Antimicrobial peptides (AMPs) have been paid considerable attention owing to their broad-spectrum antimicrobial activity and have great potential as novel antimicrobials. In this study, a novel hybrid peptide LF15-CA8 was designed on the basis of bovine lactoferricin (LfcinB) and cecropin A. The gene segment encoding LF15-CA8 was synthesized and cloned into pGEX-4T-BH to form pGEX-4T-LC1 containing one copy of the LF15-CA8 coding region. A series of recombinant vectors containing up to six multiple-copy LF15-CA8 coding regions, i.e., pGEX-4T-LCn ( n = 1–6), were subsequently constructed, and used for transformation in Escherichia coli BL21(DE3). After induction with IPTG, pGEX-4T-LC1 and pGEX-4T-LC2 transformants successfully expressed fusion proteins GST-LF15-CA8 and GST-(LF15-CA8) 2 in the form of inclusion bodies, respectively. The inclusion bodies were dissolved and the peptide was successfully released in 70 % formic acid in a single step. After purification, about 10.0 mg of the recombinant peptide LF15-CA8 with purity more than 97 % was obtained from 1 l of bacteria culture of pGEX-4T-LC2 transformants. LF15-CA8 caused an increase in antibacterial activity against Gram-positive bacterium ( Staphylococcus aureus ATCC 25923) compared with the parent peptides and did not show obvious hemolytic activity against human erythrocytes in the range of effective antibacterial concentration. These results suggest that the peptide LF15-CA8 could be a promising candidate for therapeutic applications, and may lead to a cost-effective solution for the large-scale production of AMPs.

Fusion Expression of Enterocin A in Escherichia coli and Detection of Antibacterial Activity

Fusion Expression and Purification of Enterocin A in Escherichia Coli and Antibacterial Activity Determination of MBP-enterocin A

Heterologous expression of enterocin A, a bacteriocin from Enterococcus faecium, fused to a cellulose-binding domain in Escherichia coli results in a functional protein with inhibitory activity against Listeria

Fusion Expression of Synthetic Gassericin T Gene in Escherichia Coli

Fusion Expression of Bovine Lactoferricin in Escherichia Coli

[Fusion Expression of Antimicrobial Peptides in Escherichia Coli].

Fusional Expression of Penaeidin-2 in Escherichia coli and Antibacterial Activity

High-level expression of a hybrid antimicrobial peptide LfcinB-Cecropin in Escherichia coli and its activity

Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27

Fusion Expression and Bacteriostatic Activity in Vivo of Hybrid Peptide Attacin-Thanatin

[Cloning and Expression of a Gene Encoding Shortened LfcinB(1-15)-Melittin(5-12) Hybrid Peptide in Escherichia Coli BL21(DE3)].

Biological Characteristics of the Antibacterial Peptide Fowlicidin-3 Fusion Expressed in Escherichia Coli

Expression and Purification of an Antimicrobial Peptide, Bovine Lactoferricin Derivative LfcinB-W10 in Escherichia Coli

Fusion Expression of Antibacterial and Antitumorial Peptide CM4N in Escherichia Coli and Its Activity Identification

Fusion Expression of Cecropin B-like Antibacterial Peptide in Escherichia Coli and Preparation of Its Antiserum

Fusion Expression of Chicken Gallinacin-1(Gal-1) in Escherichia Coli and Its Purification, Detection of Antibacterial Activity

Fusion Expression of Recombinant Cathelicidins Genes in Escherichia coli and Study on its Antibacterial Activity against Staphylococcus aureus in vivo

Expression of E.tenella ZJ strain 3-1E gene in E.coli

Production of Bacteriocin E50-52 by Small Ubiquitin-Related Modifier Fusion in Escherichia Coli.

Design and high-level expression of a hybrid antimicrobial peptide LF15-CA8 in Escherichia coli

Expression of Chimeric Gene of Penaeidin-3 and Penaeidin-4 in E. Coli and Its Antibacterial Activity Assay.